Company News: Page (1) of 1 - 05/31/14

PROCLAIM(SM) National Patient Registry Analysis Shows Improved Median Overall Survival in Patients with Metastatic Melanoma Treated with High-Dose Interleukin-2 (HD IL-2)

Data Support Adoption of Stable Disease as Response Criterion, Raise Intriguing Hypotheses about Sequential Therapy and Utility of IL-2 as Salvage Option

May 31, 2014 --
Our Apologies, This article is no longer available, You may have followed an outdated link.

Page: 1
Related Keywords:Pro AV, Post/Production, Presentors, Director, Business, Marketing, Standards/Initiatives, OS (Operating System), Inc., Medicine, Disease, healthcare, Cancer, Surgery, Medication, Vitamins/Nutrition, Physician, Science, Lifestyle, Medical, Biology, Cancer, Business, Science, Adults,

Source:PR Newswire. All Rights Reserved

(Click here to place a textlink on this site)

Get 10 days of free unlimited access to
What do you want to learn today? Online video tutorials to help you learn software, creative, and business skills.
Click Here!


@ Copyright, 2014 Digital Media Online, All Rights Reserved

Digital Media Online, Inc.